Outcomes of extended duration therapy for drug-susceptible cavitary pulmonary tuberculosis

BACKGROUND: Extending the continuation phase treatment duration is recommended to improve outcomes of drug-susceptible cavitary pulmonary tuberculosis (TB), but limited data are available on extended treatment outcomes. METHODS: We evaluated outcomes of 67 patients with drug-susceptible cavitary pul...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyun, Sohn, Jang Won, Sim, Yun Su, Shin, Tae Rim, Kim, Dong-Gyu, Choi, Hayoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186603/
https://www.ncbi.nlm.nih.gov/pubmed/32355790
http://dx.doi.org/10.21037/atm.2020.02.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186603/
https://www.ncbi.nlm.nih.gov/pubmed/32355790
http://dx.doi.org/10.21037/atm.2020.02.104

Ejemplares similares